For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

A virus that infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy, say researchers at ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

VU grad wins Fulbright grant Micah Koppang, a 2025 Valparaiso University graduate, has been selected for a Fulbright scholarship. Koppang, a Spanish major with a minor in political science who ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...